Sen. Mark R. Warner sold Halozyme Therapeutics (HALO)
Sen. Mark R. Warner (D-VA) · $500K–$1M · traded Nov 6, 2017
- Transaction
- Sold (full)
- Amount
- $500K–$1M
- Owner
- The member
- Traded
- Nov 6, 2017
- Disclosed
- Dec 8, 2017
- Days to disclose
- 32
- Asset type
- Stock
- As filed
- Halozyme Therapeutics, Inc.
- Industry
- Biotechnology · Healthcare
Recent Congress trades in HALO
- Oct 12, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Sold (partial) Halozyme Therapeutics HALO
$1K–$15K · Traded Sep 29, 2026 · disclosed Oct 12, 2026
- Apr 7, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Halozyme Therapeutics HALO
$1K–$15K · Traded Mar 9, 2026 · disclosed Apr 7, 2026
- Apr 7, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Sold (partial) Halozyme Therapeutics HALO
$1K–$15K · Traded Mar 24, 2025 · disclosed Apr 7, 2025
- Oct 3, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Sold (partial) Halozyme Therapeutics HALO
$1K–$15K · Traded Sep 9, 2024 · disclosed Oct 3, 2024 · Joint
- Aug 13, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
Sold Halozyme Therapeutics HALO
$15K–$50K · Traded Jul 12, 2023 · disclosed Aug 13, 2023
- Jan 13, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Sold (partial) Halozyme Therapeutics HALO
$1K–$15K · Traded Dec 6, 2022 · disclosed Jan 13, 2023 · Joint
Company context for HALO
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
HALO: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
HALO: Financial results
Filed 8-K for an event or period dated 2026-11-05. Financial results.
HALO: amended insider filing
An amended ownership report was filed. Read the original and amendment before comparing transactions.
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.